Advanced Institute for Diabetes & Endocrinology

Thyroid Cancers

Thyroid cancer is found in certain thyroid nodules, but most nodules are benign.

Types of Thyroid Cancer

Papillary Thyroid Cancer

  • Most common cancer in endocrinology (85% of thyroid cancers)
  • Very slow growing and curable
  • More common in people who have had radiation therapy earlier in life
  • Variants include:
    • Hurthle Cell
    • Tall Cell
    • Hobnail
    • Insular
    • Columnar
    • Follicular

Follicular Thyroid Cancer

  • 12% of thyroid cancers
  • Slow growing
  • More associated with older patients, especially in areas without iodine in the diet
  • Has variants requiring special attention

Medullary Thyroid Cancer

  • 1-2% of thyroid cancers
  • Usually hereditary, can be associated with syndromes like MEN
  • Some cases are random
  • Treated with surgery and occasionally radiation therapy
  • Calcitonin serves as a tumor marker

Anaplastic Thyroid Cancer

  • 0.01% of thyroid cancers
  • Rare and extremely aggressive
  • Associated with specific gene mutations
  • High mortality rate
  • Often detected at an advanced stage
  • Treated with surgery, chemotherapy, and radiation therapy

Treatment of Thyroid Cancers

  • Diagnosis by fine needle aspiration (biopsy)
  • Thyroid surgery (usually total thyroidectomy)
  • Thyroid hormone replacement pill after surgery
  • Papillary cancer may require additional radioactive iodine treatment
  • Levothyroxine dose may be adjusted to reduce recurrence risk
  • Note: Stop biotin supplements 7 days before lab tests
  • Specific treatments:
    • Medullary: Surgery and occasional radiation
    • Anaplastic: Chemotherapy and radiation

Thyroid Hormone Replacement

  • Levothyroxine (T4):
    • Generic medication identical to human thyroid hormone
    • Synthetically produced
    • Body converts T4 to T3 as needed
  • Avoid Armour thyroid or similar
  • Liothyronine (T3) used only in specific situations:
    • Can increase heart palpitation risks
    • May thin bones

Survival Rates

  • Papillary:
    • 5-year survival > 90% when diagnosed before age 65
    • Depends on tumor variant and metastasis
  • Follicular:
    • 10-year survival 80-95%
    • Varies by age and disease stage
  • Medullary:
    • 10-year survival 98% if surgery resolves calcitonin levels
    • Approximately 70% survival if calcitonin persists
  • Anaplastic:
    • Usually fatal within a year
    • Focus on patient and family quality of life

Resources